n Cardiovascular Journal of South Africa - Two- and three-drug therapy with candesartan cilexetil (Atacand®) successful in patients with severe hypertension : drug trends




A recent double-blind study of the treatment of hypertensive patients whose blood pressure remained above target on two-drug combinations, showed that a strategy of adding candesartan cilexetil (Atacand®) or of switching to candesartan and hydrochlorothiazide produced further reductions in blood pressure while maintaining tolerability. In addition, the results showed a trend in favour of the three-drug, standard-dose approach, compared to the two-drug, high-dose approach.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error